收藏切换
Meta-analysis of novel oral factor Ⅹa inhibitors in the treatment of pulmonary embolism in middle-aged and elderly patients
收藏切换
Qinghuan LI1, 2a, Haifeng LI2b, Ling ZHANG2a, Jiali ZHU1, Zonglu LI3, Xiaona TONG2a, *
World Clinical Drug | 2026, 47(2) : 184 - 197
Less
收藏切换
World Clinical Drug | 2026, 47(2): 184-197
• Article •
Meta-analysis of novel oral factor Ⅹa inhibitors in the treatment of pulmonary embolism in middle-aged and elderly patients
Full
Qinghuan LI1, 2a, Haifeng LI2b, Ling ZHANG2a, Jiali ZHU1, Zonglu LI3, Xiaona TONG2a, *
Affiliations
  • 1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China
  • 2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China
  • 2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China
  • 3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China
Published: 2026-02-10 doi: 10.13683/j.wph.2026.02.011
Outline
收藏切换
Objective

To systematically evaluate the clinical efficacy and safety of novel oral factor Ⅹa inhibitors(such as rivaroxaban, apixaban, edoxaban, etc.) in the treatment of middle-aged and elderly patients with pulmonary embolism, to provide evidence-based references for the clinical application of such drugs.

Methods

The databases of CNKI, Wanfang Data, VIP, PubMed, Cochrane Library, Web of Science, and Embase were searched by computer to collect randomized controlled trials(RCTs) on the treatment of pulmonary embolism in middle-aged and elderly patients with novel oral factorⅩa inhibitors. The retrieval time limit for all databases was from the establishment of the databases to December 2024. After two researchers independently screened the literature, extracted the data, and evaluated the bias risks of the included studies, the RevMan 5.4 software was used for meta-analysis.

Results

A total of 28 RCTs were included, involving 73,764 patients. The medications in the experimental group included novel oral factor Ⅹa inhibitors such as rivaroxaban, apixaban, and edoxaban. The results of the meta-analysis showed that, compared with traditional anticoagulant drugs, novel oral factor Ⅹa inhibitors could significantly improve the clinical effective rate[odds ratio(OR)=1.68, 95% confidence interval·(CI): 1.32—2.15, P<0.001], and there was no significant increase in the risk of bleeding (clinically relevant non-major bleeding OR=0.97, 95%CI: 0.78—1.21, P=0.77; minor bleeding OR=1.21, 95%CI: 0.91—1.38, P=0.29).

Conclusion

Current evidence shows that novel oral factor Ⅹa inhibitors have significant clinical efficacy in the treatment of middle-aged and elderly patients with pulmonary embolism, and compared with traditional anticoagulant drugs, they do not significantly increase the risk of bleeding.

novel oral factor Ⅹa inhibitors  /  pulmonary embolism  /  meta-analysis
李晴欢, 李海峰, 张玲, 朱家丽, 李宗露, 佟晓娜. 新型口服Ⅹa因子抑制剂治疗中老年肺栓塞的meta分析. 世界临床药物, 2026 , 47 (2) : 184 -197 . DOI: 10.13683/j.wph.2026.02.011
Qinghuan LI, Haifeng LI, Ling ZHANG, Jiali ZHU, Zonglu LI, Xiaona TONG. Meta-analysis of novel oral factor Ⅹa inhibitors in the treatment of pulmonary embolism in middle-aged and elderly patients[J]. World Clinical Drug, 2026 , 47 (2) : 184 -197 . DOI: 10.13683/j.wph.2026.02.011
Year 2026 volume 47 Issue 2
58
13
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.02.011
  • Receive Date:2025-07-28
  • Online Date:2026-11-05
  • Published:2026-02-10
Article Data
Affiliations
History
  • Received:2025-07-28
Funding
Affiliations
    1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China
    2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China
    2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China
    3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.02.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT